At the time of writing, Immunovant Inc [IMVT] stock is trading at $16.0, up 3.43%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IMVT shares have gain 3.29% over the last week, with a monthly amount glided 9.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Immunovant Inc [NASDAQ: IMVT] stock has seen the most recent analyst activity on March 03, 2025, when Jefferies initiated its Hold rating and assigned the stock a price target of $20. Previously, Wolfe Research downgraded its rating to Peer Perform on January 03, 2025. Oppenheimer reiterated its Outperform rating and increased its price target to $53 on October 09, 2024. Oppenheimer initiated its recommendation with a Outperform and recommended $50 as its price target on March 28, 2024. Goldman started tracking with a Buy rating for this stock on March 13, 2024, and assigned it a price target of $50. In a note dated February 20, 2024, JP Morgan initiated an Overweight rating and provided a target price of $51 on this stock.
For the past year, the stock price of Immunovant Inc fluctuated between $12.72 and $34.47. Currently, Wall Street analysts expect the stock to reach $42.83 within the next 12 months. Immunovant Inc [NASDAQ: IMVT] shares were valued at $16.0 at the most recent close of the market. An investor can expect a potential return of 167.69% based on the average IMVT price forecast.
Analyzing the IMVT fundamentals
An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.46 points at the first support level, and at 14.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.34, and for the 2nd resistance point, it is at 16.68.
Ratios To Look Out For
It is important to note that Immunovant Inc [NASDAQ:IMVT] has a current ratio of 11.16. Further, the Quick Ratio stands at 11.16, while the Cash Ratio is 10.38.
Transactions by insiders
Recent insider trading involved WILLIAM MACIAS, Officer, that happened on Jun 13 ’25 when 50000.0 shares were purchased. Officer, WILLIAM MACIAS completed a deal on Jun 03 ’25 to buy 80000.0 shares. Meanwhile, Former Director GEORGE V MIGAUSKY bought 21812.0 shares on May 21 ’25.
